ANDA 217276, held by Zydus Pharms. Ephedrine Sulfate.
As of Nov 16, 2026, ANDA 217276 (Ephedrine Sulfate), held by Zydus Pharms, was first approved by FDA on May 16, 2023, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 16, 2023 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Ephedrine Sulfate50MG/ML (50MG/ML) ยท solution;intravenous | Ephedrine Sulfate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters